Planning and Provision of Drug Misuse Services

APPENDIX G

Report of an Independent Review of Drug Treatment Services in England: The Polkinghorne Report

SUMMARY OF RECOMMENDATIONS

The Polkinghorne Task Force reviewed drug treatment services in England and made recommendations for improvement based on its findings. Although based specifically on service provision in England, the report contains much to inform the planning and provision of care and treatment services in Scotland, and this guidance, as a whole, has sought to clarify the areas where service improvement can be made.

It does not stand alone, however, but builds on the advice provided in the Ministerial Drugs Task Force Report of 1994, which remains the strategic framework for tackling drug misuse in Scotland today, and which covers all the main areas of service provision.

A summary of the Polkinghorne recommendations is given below. It is, of course, for those responsible for ensuring the provision of drug misuse services, through the local Drug Action Team (DAT), to decide the priority to be afforded to the various services within their allocated resources.

SERVICE RECOMMENDATIONS
PREVENTIVE SERVICES
Outreach programmes 4.2.8 Better management, monitoring and support systems should be introduced for outreach services. Outreach services should clearly identify their aims and objectives and collect data on number of contacts made, the effect of contact, costs per contact and on turnover of clients.

4.3.11 Purchasers should consider the needs of young people at risk of drug misuse and those who are misusing drugs within a comprehensive local assessment of need. Meeting the needs of young drug misusers is likely to include:

- youth services which are aware of and responsive to possible drug problems;

- drugs services specifically dedicated to young people;

- arrangements for access, where appropriate to "mainstream" drug services.

ACUTE, SHORT TERM CARE

Hospital Drug Dependence Unit care; acute assessment facilities 5.10.14 Purchasers should:

- recognise that specialist inpatient (and residential) detoxification programmes can have significant impact on certain types of drug misusers who may not benefit from outpatient detoxification.

- ensure that those needing detoxification are admitted within a specified time from identification of need. Given the levels of drug related and psychological problems likely to be present in clients in need of residential care, prompt access is likely to be important.

- gather cost information on in and outpatient detoxification programmes and monitor outcomes to inform them of the relative cost effectiveness of the different approaches.

- health authorities should identify from local needs assessments, the likely demand for inpatient services, and contract for that level in advance so that such services can undertake proper planning to meet the expected level of need.

Generic A&E services 4.5.4 All Accident & Emergency (A&E) Department staff should receive basic drug awareness training.

- Purchasers should discuss with A&E providers the practicalities of collecting data on drug misuse attendance at A and E Departments.

- A&E Departments should display posters and have leaflets available on drug misuse, health promotion and harm minimisation, and where to get help from local drug treatment services.

- Purchasers should explore with A&E providers the scope for developing needle exchanges in A&E Departments.

Hospital detoxification; Community detoxification services; Community drug crisis intervention services 5.5.10 Purchasers should ensure detoxification services are always complemented by counselling and social support.

Purchasers should establish outcome criteria for detoxification, based on evidence of safety and minimal discomfort, and the percentages of patients who complete the treatment and who go on to further treatment.

SUPPORT AND REHABILITATION

Inpatient unit care 5.10.14 Purchasers should:

- recognise that specialist inpatient (and residential) detoxification programmes can have significant impact on certain types of drug misusers who may not benefit from outpatient detoxification

- ensure that those needing detoxification are admitted within a specified time from identification of need. Given the levels of drug related and psychological problems likely to be present in clients in need of residential care, prompt access is likely to be important.

- gather cost information on in and outpatient detoxification programmes and monitor outcomes to inform them of the relative cost effectiveness of the different approaches.

Health authorities should:

- identify, from local needs assessments, the likely demand for inpatient services, and contract for that level in advance so that such services can undertake proper planning to meet the expected level of need.

Residential care:

    Minnesota model
    Christian
    Therapeutic communities
    Other models

5.9.13

- Purchasers should ensure access to residential care for those likely to benefit.

- Given the levels of drug related and psychological problems likely to be present in clients in need of residential care, prompt access is likely to be important. Purchasers should ensure admission within a specified time from identification of need.

- Purchasers need to be able to meet the varied needs of their clients. Given the range of distinct philosophical approaches to rehabilitation adopted by centres in England, they should have access to centres of the three main types: therapeutic communities, 12 step and Christian based houses.

- Until more comprehensive and longer term outcome data become available from the National Treatment Outcome Research Study, purchasers will need to look at the rates of retention in the services they purchase. The Task Force considered that, as a preliminary measure, more than 50% should remain in treatment at the end of 4weeks - a target already achieved by some centres. Purchasers should take steps to follow up people who drop out to establish why and thus inform future purchasing strategies.

Methadone reduction programmes 5.6.11

- Reduction programmes should review the status of clients and their treatment contract on a regular basis, egonce a month, according to the length of the programme.

- Purchasers should consider how to ensure clients who have become drug free can have access to appropriate support through further outpatient attendances, community projects or self-help groups such as Narcotics Anonymous.

Methadone maintenance programmes 5.7.16 Purchasers should:

- ensure that the programme content, structure and setting of methadone maintenance programmes reflects the needs of clients;

- expect programmes to review the status of the client on a regular basis (eg every 3months) to see if they have reached a stage where they are readier to contemplate reduction leading to abstinence.

- monitor the impact of treatment on other problem domains (eg crime etc).

- Study the longer term results from the National Treatment Outcomes Research Study to see if structured programmes produce better outcomes, and to identify optimum dispensing arrangements.

Hospital outpatient and other community-based clinics 6.3.8 Health and Social Services purchasers should have a dedicated resource to deal with drug misuse and should work with others to ensure organisational barriers do not slow down speed of assessment and response.

Contracts between purchasers and providers against which overall performance is assessed should incorporate specific quality standards which ensure individual clients:

- have the right to an assessment of individual need (where appropriate) within a specified number of working days;

- have the right of access to specialist services within a specified maximum waiting time;

- have the right to respect for privacy, dignity and confidentiality, and an explanation of any (exceptional) circumstances in which information will be divulged to others;

- have the right of access to a complaints procedure;

- have the right to full information about treatment options and informed involvement in making decisions on treatment;

- have the right, when referred to consultant, to be referred for a second opinion, in consultation with their GP;

- can expect the right to an individual care and treatment plan;

DATs should initially monitor local performance standards, but this should be with a view to development of national targets.

Opening hours

6.4.3

Purchasers should identify when users need services to be open, taking account of the needs of particular groups such as young people, and reflect this in contracts.

Opening times should be widely publicised.

Counselling within the NHS and voluntary sector street agencies and community drug projects 5.4.15 Counselling should be recognised as a core component of drug treatment and not just an optional subsidiary to other treatments.

There is a need for purchasers and providers to distinguish clearly between structured counselling approaches, with clearly defined goals, and information and advice giving.

Delivery of structured counselling needs training and skills and purchasers should encourage this by requiring services to increase their numbers of accredited counsellors.

Further research is needed to evaluate the effectiveness of different counselling approaches.

Services for stimulant users 5.11.5 Provision should be made for services to be able to deal with the treatment needs of amphetamine drug misusers heavily dependent on amphetamines.

5.11.28 All specialist drug agencies should be prepared to offer treatment to primary cocaine users.

Services should provide rapid access to treatment.

Purchasers need to monitor that cocaine drug misusers are getting appropriate and adequate treatment.

Services specifically for young drug misusers 4.3.11 Purchasers should consider the needs of young people at risk of drug misuse and those who are misusing drugs within a comprehensive local assessment of need. Meeting the needs of young drug misusers is likely to include:

- youth services which are aware of and responsive to possible drugs problems;

- drugs services specifically dedicated to young people;

- arrangements for access, where appropriate, to "mainstream" drug services.

4.4.6 The Task Force endorsed the recommendations of the Social Services Inspectorate. Social Services Departments should build on the positive start which may have been made and make sure that adequate priority is given to services for drug misusers and especially young people misusing drugs.

Services specifically for women 6.5.3 Purchasers and providers should take account of particular needs (eg childcare facilities for drug misusing mothers) and reflect these in contracts.
Services for ethnic minorities 6.5.6 Purchasers should work with representatives of ethnic minority groups to identify and take account of any particular service needs they identify and reflect these in contracts.
Care in Family Health Services settings - GP surgeries 4.7.19 GPs have responsibility for the physical health needs of drug misusers within the provision of general medical services and should be encouraged to identify drug misuse, promote harm minimisation and where appropriate refer to specialist services.

The process of "shared care", with appropriate support for GPs, should be available as widely as possible. Health authorities should encourage its expansion to enable GPs to take overall clinical responsibility for drug misusers and agree with a specialist a treatment plan which may involve the GP prescribing substitute opiate drugs.

GPs should be sufficiently skilled to identify a problem drug misuser who may be consulting them for other, perhaps related, problems. This may require a programme of specialised training for some GPs.

GPs should know to whom they can refer in a crisis and for ongoing support, either from specialist drug workers, such as community psychiatric nurses, regularly attending their clinics, or by access to a named key worker in a local specialist agency.

The service provided by the GP should be agreed between the Local Medical Committee and specialist services and should clearly set out the respective roles of the GP and the specialist services, and the support the GP can expect in delivering the service.

Purchasers should ensure that GPs have straightforward access to urine testing facilities.

Where they have concerns about compliance with consumption arrangements GPs should have access to facilities where supervised consumption can take place.

The agreement between the Local Medical Committee and specialist services for the provision of shared care should include arrangements for referral, assessment and management. Purchasers should monitor local arrangements and ensure adequate controls are in place.

Where the service is defined as exceeding the requirements of general medical services, following consultation and agreement with the profession, the question of additional payment for the delivery of a specialist service needs to be considered.

Care in Family health Service settings - pharmacies 4.8.11 The Department of Health should consider setting up pilot projects to investigate the potential for pharmacies to expand the range of services they offer to drug misusers, including the supervised consumption of controlled drugs or other medication on the premises where appropriate. Results should be used to draw up guidelines and ensure appropriate training is available for participating pharmacies and their staff.
Care in Family Health Service settings - Health Authorities 4.8.11 Health Authorities should:

- ensure a comprehensive coverage of needle-exchange facilities, using pharmacy outlets as well as specialist agency services, outreach workers and potentially A&E departments;

- consider the extent to which participating pharmacies can deliver health promotion messages. These could include advice to protect others as well as drug misusers themselves, for example on storing controlled drugs to prevent harm to children and to educate misusers on the risk of, and methods to avoid, overdose;

- take steps to improve links between pharmacies and prescribers and feedback in both directions, and ensure participating pharmacies have effective links with specialist services for advice.

Free standing needles/syringe exchanges 5.3.19 Purchasers should:

- ensure comprehensive local coverage by syringe exchange schemes.

- ensure that minimum service specifications for exchange schemes include provision of basic health checks for clients and that exchange scheme staff receive training to enable them to provide these.

- require all exchange schemes to collect basic client data. They should also collect information on costs including cost per exchange.

- agree targets with syringe exchange schemes on volume of clients, frequency of visit, duration of contact and percentage of referrals to treatment. Details of targets should be set locally.

- review arrangements for delivering HepatitisB vaccinations locally and monitor progress towards universal vaccination of drug service clients.

Self help family help groups/networks 5.2.11 Purchasers should be aware of the possible benefits of self help networks and should encourage the development of a wide range of self-help groups and self help treatments.

Information about existing groups such as Narcotics Anonymous and Families Anonymous, and services such as ADFAM, should be made available in all treatment settings.

Where possible, self help groups should be evaluated more rigorously.

Arrest and bailee referral schemes 4.10.11 HM Inspectors of Constabulary should take steps to encourage full and consistent use of cautioning of drug misusers by local police.

Arrest referral schemes should be provided at each police station. DATs should consider whether there are cost benefits to provision of support from specialist drug workers.

DATs should explore ways of monitoring the effectiveness of cautioning and arrest referral schemes as a means of reducing re-offending.

DATs should encourage their police representative to consider training needs of police surgeons so they are equipped with the skills to manage the clinical needs of drug misusers within police custody.

Probation linked care 4.11.10 Through their membership of DATs, probation services should consider ways of maximising joint working and, where appropriate, pooling resources with other statutory bodies such as health and local authorities to maximise the benefits for treatment of drug misusers in their care.
Prison throughcare/release schemes 4.13.5 Drug misusers should have immediate access to appropriate treatment programmes on release. This is essential to maximising the treatment opportunity we hope will be available within prisons, as well as reducing the risk of overdose inherent in a return to use of street drugs after a period of abstinence.

In those areas with prisons, DATs should review the arrangements for managing drug misusers on release and ensuring that effective arrangements exist for referring drug misusers to appropriate services.

Social Services 4.4.6 The Task Force endorsed the recommendations of the Social Services Inspectorate report. Social Services Departments should build on the positive start which many have made and make sure that adequate priority is given to services for drug misusers and especially young people misusing drugs.
Alcohol dependency services 6.5.12 Purchasers and providers should ensure that people working in both drug and alcohol treatment services are aware of the need to identify and respond to overlapping alcohol and drug problems.
Psychiatric service 6.5.10 Purchasers and providers should ensure that people working in both drugs and mental illness services are aware of the need to identify and respond to problems of combined psychiatric illness and drug misuse.
Other health care:

    Maternity;
    Dentistry;
    Hepatitis B vaccination

4.6.6 Maternity staff should receive basic drug awareness training.

Purchasers should explore the need for maternity drug liaison workers.

5.3.19 Purchasers should review arrangements for delivering Hepatitis B vaccinations locally and monitor progress towards universal vaccination of drug service clients.

Training 6.6.7 Professional bodies should review the extent to which they have implemented the Advisory Council on the Misuse of Drugs' 1990 recommendations.

Purchasers should require providers to examine skill levels of staff working with drug misusers and make sure that service budgets include enough to enable the right training to be undertaken.

6.7.6 People appointed as service directors should have good management skills and in post training should be made available to them, and other managers, as appropriate.

Voluntary sector management committees and NHS Trust line managers should recognise their own responsibilities to ensure these directors perform effectively.

Note: Agencies can provide multiple services in a single community setting. Many of the Polkinghorne recommendations - such as those on services user rights and service quality management - apply across settings and services.